跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRECONDYV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TRECONDYV
Authorized
STANDARD
TRECONDYV
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
13a9fd2470183d12
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
13a9fd2470183d12
Drug Approval Canada Name
TRECONDYV
Product Name
TRECONDYV
Status
Marketed
Status Date
2021-08-31
Original Market Date
2021-08-31
Din
02517388
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AB02 TREOSULFAN
Atc Name
l 01 ab 02
Aig Number
0163010002
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
TREOSULFAN
5 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
13a9fd2470183d12
Type
Standard
Back to Health Canada Approvals